The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Open accessAbstract
Current genome-editing technologies introduce double-stranded (ds) DNA breaks at a target locus as the first step to gene correction. Although most genetic diseases arise from point mutations, current approaches to point mutation correction are inefficient and typically induce an abundance of random insertions and deletions (indels) at the target locus resulting from the cellular response to dsDNA breaks. Here we report the development of 'base editing', a new approach to genome editing that enables the direct, irreversible conversion of one target DNA base into another in a programmable manner, without requiring dsDNA backbone cleavage or a donor template. We engineered fusions of CRISPR/Cas9 and a cytidine deaminase enzyme that retain the ability to be programmed with a guide RNA, do not induce dsDNA breaks, and mediate the direct conversion of cytidine to uridine, thereby effecting a C→T (or G→A) substitution. The resulting 'base editors' convert cytidines within a window of approximately five nucleotides, and can efficiently correct a variety of point mutations relevant to human disease. In four transformed human and murine cell lines, second- and third-generation base editors that fuse uracil glycosylase inhibitor, and that use a Cas9 nickase targeting the non-edited strand, manipulate the cellular DNA repair response to favour desired base-editing outcomes, resulting in permanent correction of ~15-75% of total cellular DNA with minimal (typically ≤1%) indel formation. Base editing expands the scope and efficiency of genome editing of point mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The discovery of spontaneous hydrolytic deamination of cytosine converting C-G base pairs to T-A in humans highlighted the potential of base editing for direct base pair conversion without requiring double-strand breaks or homology repair templates (Komor, et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor, et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the same paper, with enhanced third-generation base editors, Komor et al. achieved >30-fold greater editing efficiency in various human cell lines when compared to HDR-mediated Cas9 editing, with fewer indel formation.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“First-generation base editors had limitations such as low efficiency and base excision repair (BER) activity that reversed edits (Komor et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Second-generation editors, such as APOBEC-XTEN-dCas9-UGI, added an uracil DNA glycosylase inhibitor (UGI) to improve C-to-T conversion (Komor et al., 2016) but still had <0.1% indel formation, limiting precision (Azameti and Dauda, 2021).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Fusion of a cytidine deaminase (rAPOBEC1) to a partially inactive nickase-Cas9(D10A) protein results in a cytidine base editor (CBE) that allows for C > T base changes via a uracil intermediate28”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Coupling this Cas9n or dCas9, the catalytically “dead” variant of Cas9, with a cytidine deaminase enzyme enables the gRNA-mediated deamination of cytosine (C) bases in the non-target DNA strand into uracil (U), which shares the base-pairing properties of thymine (T) [82].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredIn the citing paper
“Variations on these methods enable the functional evaluation of genes (via knockout screens124), regulatory elements (using CRISPR interference and CRISPR activation screens125,126), and genetic variants (base editors127) at increasing scale and resolution29.”
From A brief history of human disease genetics (2020) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Flagged first, then by citations
1 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,035
Li, C., Zong, Y., Jin, S., Zhu, H., Lin, D., Li, S., Qiu, J., Wang, Y., & Gao, C. (2020) · Genome biology · doi:10.1186/s13059-020-02051-x · Cited by 80
Development and Application of CRISPR/Cas in Microbial Biotechnology
Ding, W., Zhang, Y., & Shi, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00711 · Cited by 81
Lineage tracing and analog recording in mammalian cells by single-site DNA writing
Loveless, T. B., Grotts, J. H., Schechter, M. W., Forouzmand, E., Carlson, C. K., Agahi, B. S., Liang, G., Ficht, M., Liu, B., Xie, X. S., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00769-8 · Cited by 79
Xia, X., Cheng, X., Li, R., Yao, J., Li, Z., & Cheng, Y. (2021) · Theoretical and Applied Genetics · doi:10.1007/s00122-021-03874-3 · Cited by 78
Application of CRISPR/Cas9 in Alzheimer’s Disease
Lu, L., Xi, Y., Cai, Y., Sun, M., & Yang, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.803894 · Cited by 79
Synthetic lethal strategies for the development of cancer therapeutics
Ngoi, N. Y. L., Gallo, D., Torrado, C., Nardo, M., Durocher, D., & Yap, T. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00966-z · Cited by 81
Expanding the genome-targeting scope and the site selectivity of high-precision base editors
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2020) · Nature Communications · doi:10.1038/s41467-020-14465-z · Cited by 79
NEMO Links Nuclear Factor-κB to Human Diseases
Maubach, G., Schmädicke, A.-C., & Naumann, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.10.004 · Cited by 77
Highly efficient and precise base editing in discarded human tripronuclear embryos
Li, G., Liu, Y., Zeng, Y., Li, J., Wang, L., Yang, G., Chen, D., Shang, X., Chen, J., Huang, X., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0458-7 · Cited by 77
Development and application of CRISPR/Cas9 technologies in genomic editing
Zhang, C., Quan, R., & Wang, J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy120 · Cited by 80
Evolution of plant mutagenesis tools: a shifting paradigm from random to targeted genome editing
Shelake, R. M., Pramanik, D., & Kim, J. (2019) · Plant Biotechnology Reports · doi:10.1007/s11816-019-00562-z · Cited by 79
Enabling large-scale genome editing at repetitive elements by reducing DNA nicking
Smith, C. J., Castanon, O., Said, K., Volf, V., Khoshakhlagh, P., Hornick, A., Ferreira, R., Wu, C., Güell, M., Garg, S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa239 · Cited by 83
Broadening the GMO risk assessment in the EU for genome editing technologies in agriculture
Kawall, K., Cotter-Howells, J. D., & Then, C. (2020) · Environmental Sciences Europe · doi:10.1186/s12302-020-00361-2 · Cited by 84
CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
Azangou‐Khyavy, M., Ghasemi, M., Khanali, J., Boroomand-Saboor, M., Jamalkhah, M., Soleimani, M., & Kiani, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02062 · Cited by 80
CRISPR/Cas9 technology for improving agronomic traits and future prospective in agriculture
Rao, M. J., & Wang, L. (2021) · Planta · doi:10.1007/s00425-021-03716-y · Cited by 78
Applications of CRISPR Genome Engineering in Cell Biology
Wang, F., & Qi, L. S. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.08.004 · Cited by 79
Lee, S., Ding, N., Sun, Y., Yuan, T., Li, J., Yuan, Q., Liu, L., Yang, J., Wang, Q., Kolomeisky, A. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1773 · Cited by 81
Classification of CRISPR/Cas system and its application in tomato breeding
Chaudhuri, A., Halder, K., & Datta, A. (2022) · Theoretical and Applied Genetics · doi:10.1007/s00122-021-03984-y · Cited by 77
Emergent CRISPR–Cas-based technologies for engineering non-model bacteria
Volke, D. C., Orsi, E., & Nikel, P. I. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102353 · Cited by 78
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Ghosh, D., Venkataramani, P., Nandi, S., & Bhattacharjee, S. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0726-0 · Cited by 83
Hwang, S., Lee, N., Cho, S., Palsson, B. Ø., & Cho, B. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00087 · Cited by 78
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy
Mbakam, C. H., Lamothe, G., Tremblay, G., & Tremblay, J. P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01197-9 · Cited by 81
Deep learning models to predict the editing efficiencies and outcomes of diverse base editors
Kim, N., Choi, S.-C., Kim, S., Song, M., Seo, J. H., Min, S., Park, J., Cho, S., & Kim, S. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01792-x · Cited by 78
Haldrup, J., Andersen, S., Labial, A. R. L., Wolff, J. H., Frandsen, F. P., Skov, T. W., Rovsing, A. B., Nielsen, I. H., Jakobsen, T. S., Askou, A. L., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad676 · Cited by 78
Alves, C. R. R., Ha, L. L., Yaworski, R., Sutton, E. R., Lazzarotto, C. R., Christie, K. A., Reilly, A., Beauvais, A., Doll, R. M., de la Cruz, D., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01132-z · Cited by 72
Martyn, G. E., Wienert, B., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2019) · Blood · doi:10.1182/blood-2018-07-863951 · Cited by 75
A multiplex guide RNA expression system and its efficacy for plant genome engineering
Oh, Y., Lee, B., Kim, H., & Kim, S. (2020) · Plant Methods · doi:10.1186/s13007-020-00580-x · Cited by 74
Reverse Transcriptase: From Transcriptomics to Genome Editing
Martín-Alonso, S., Frutos-Beltrán, E., & Menéndez‐Arias, L. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.06.008 · Cited by 76
Molecular evolution and functional modification of plant miRNAs with CRISPR
Deng, F., Zeng, F., Shen, Q., Abbas, A., Cheng, J., Jiang, W. J., Chen, G. J., Shah, A. N., Holford, P., Tanveer, M., et al. (2022) · Trends in Plant Science · doi:10.1016/j.tplants.2022.01.009 · Cited by 74
Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities
Liu, S. S., & Yang, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.867453 · Cited by 79
CRISPR-Cas-Based Engineering of Probiotics
Liu, L., Helal, S. E., & Peng, N. (2023) · BioDesign Research · doi:10.34133/bdr.0017 · Cited by 79
Bonnycastle, K., Davenport, E. C., & Cousin, M. A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15035 · Cited by 78
Nucleic Acid Databases and Molecular-Scale Computing
Song, X., & Reif, J. (2019) · ACS Nano · doi:10.1021/acsnano.9b02562 · Cited by 73
Coelho, M. A., Li, S., Pane, L. S., Firth, M. A., Ciotta, G., Wrigley, J. D. J., Cuomo, M. E., Maresca, M., & Taylor, B. (2018) · BMC Biology · doi:10.1186/s12915-018-0617-1 · Cited by 75
Zhang, J., Sun, H., Guo, S., Ren, Y., Li, M., Wang, J., Zhang, H., Gong, G., & Xu, Y. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.19.01409 · Cited by 73
Prime Editing: Genome Editing for Rare Genetic Diseases Without Double-Strand Breaks or Donor DNA
Matsoukas, I. G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00528 · Cited by 65
Gene Editing by Extracellular Vesicles
Kostyushev, D. S., Kostyusheva, A., Brezgin, S., Vv, S., Volchkova, E. V., Lukashev, A. N., & Chulanov, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197362 · Cited by 75
Systematic optimization of Cas12a base editors in wheat and maize using the ITER platform
Gaillochet, C., Fernández, A. P., Goossens, V., D’Halluin, K., Drozdzecki, A., Shafie, M., Duyse, J. V., Isterdael, G. V., Gonzalez, C., Vermeersch, M., et al. (2023) · Genome biology · doi:10.1186/s13059-022-02836-2 · Cited by 78
Recent application of CRISPR-Cas12 and OMEGA system for genome editing
Badon, I. W., Oh, Y., Kim, H., & Lee, S. H. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.11.013 · Cited by 75
Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects
Cetin, B., Erendor, F., Ekşi, Y. E., Şanlioğlu, A. D., & Şanlıoğlu, S. (2025) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2025.10 · Cited by 80
Principles of and strategies for germline gene therapy
Wolf, D. P., Mitalipov, P. A., & Mitalipov, S. M. (2019) · Nature Medicine · doi:10.1038/s41591-019-0473-8 · Cited by 75
Li, Q., Sapkota, M., & van der Knaap, E. (2020) · Horticulture Research · doi:10.1038/s41438-020-0258-8 · Cited by 73
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
Lim, K. R. Q., Yoon, C., & Yokota, T. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8040038 · Cited by 75
Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System
Song, Y., Liu, Z., Zhang, Y., Chen, M., Sui, T., Lai, L., & Li, Z. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.019 · Cited by 74
Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa
Meng, D., Ragi, S. D., & Tsang, S. H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.08.012 · Cited by 75
Recent Advances in the Application of CRISPR/Cas9 Gene Editing System in Poultry Species
Khwatenge, C. N., & Nahashon, S. N. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.627714 · Cited by 76
Engineered bacterial orthogonal DNA replication system for continuous evolution
Tian, R., Zhao, R., Guo, H., Yan, K., Wang, C., Lu, C., Lv, X., Li, J., Liu, L., Du, G., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01387-2 · Cited by 72
High-throughput evaluation of genetic variants with prime editing sensor libraries
Gould, S. I., Wuest, A. N., Dong, K., Johnson, G. A., Hsu, A., Narendra, V. K., Atwa, O., Levine, S. S., Liu, D. R., & Rivera, F. J. S. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02172-9 · Cited by 73
Self-citationHwang, G., Lee, S., Oh, M., Kim, S., Habib, O., Jang, H., Kim, H. S., Kim, Y., Kim, C. H., Kim, S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01277-5 · Cited by 83
Self-citationA genome-wide atlas of human cell morphology
Ramezani, M., Weisbart, E., Bauman, J., Singh, A. K., Yong, J., Lozada, M., Way, G. P., Kavari, S. L., Diaz, C., Leardini, E., et al. (2025) · Nature Methods · doi:10.1038/s41592-024-02537-7 · Cited by 74
Li, Q., Li, Y., Yang, S., Huang, S., Yan, M., Ding, Y., Tang, W., Lou, X., Yin, Q., Sun, Z., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0202-4 · Cited by 72
Houston, R. D., & Macqueen, D. J. (2018) · Animal Genetics · doi:10.1111/age.12748 · Cited by 72
Expanding C–T base editing toolkit with diversified cytidine deaminases
Cheng, T., Li, S., Yuan, B., Wang, X., Zhou, W., & Qiu, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-11562-6 · Cited by 74
Prime Editing: A New Way for Genome Editing
Marzec, M., Brąszewska-Zalewska, A., & Hensel, G. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.004 · Cited by 72
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71
May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
Brookhouser, N., Raman, S., Potts, C., & Brafman, D. A. (2017) · Cells · doi:10.3390/cells6010005 · Cited by 75
Legut, M., Daniloski, Z., Xue, X., McKenzie, D., Guo, X., Wessels, H., & Sanjana, N. E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.010 · Cited by 71
Panel), E. P. O. G. M. O. (. G., Naegeli, H., Bresson, J., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Firbank, L. G., Guerche, P., Hejátko, J., Moreno, F. J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6299 · Cited by 77
Wang, G., Xu, Z., Wang, F., Huang, Y., Xin, Y., Liang, S., Li, B., Si, H., Sun, L., Wang, Q., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01232-3 · Cited by 71
Schimmel, J., Muñoz-Subirana, N., Kool, H., van Schendel, R., van der Vlies, S., Kamp, J. A., de Vrij, F. M. S., Kushner, S. A., Smith, G. C. M., Boulton, S. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112019 · Cited by 72
Future insights in fungal metabolic engineering
Wakai, S., Arazoe, T., Ogino, C., & Kondo, A. (2017) · Bioresource Technology · doi:10.1016/j.biortech.2017.04.095 · Cited by 71
Strategies for In Vivo Genome Editing in Nondividing Cells
Nami, F., Basiri, M., Satarian, L., Curtiss, C., Baharvand, H., & Verfaillie, C. M. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.03.004 · Cited by 73
Jing, X., Xie, B., Chen, L., Zhang, N., Jiang, Y., Qin, H., Wang, H., Hao, P., Yang, S., & Li, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky433 · Cited by 71
CRISPR-based genome editing in wheat: a comprehensive review and future prospects
Kumar, R., Kaur, A., Pandey, A., Mamrutha, H. M., & Singh, G. P. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04761-3 · Cited by 70
Microbial Base Editing: A Powerful Emerging Technology for Microbial Genome Engineering
Wang, Y., Liu, Y., Zheng, P., Sun, J., & Wang, M. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.06.010 · Cited by 72
New prospects on the horizon: Genome editing to engineer plants for desirable traits
Iqbal, Z., Iqbal, M. S., Ahmad, A., Memon, A. G., & Ansari, M. I. (2020) · Current Plant Biology · doi:10.1016/j.cpb.2020.100171 · Cited by 70
CRISPR-based metabolic pathway engineering
Zhao, D., Zhu, X., Zhou, H., Sun, N., Wang, T., Bi, C., & Zhang, X. (2020) · Metabolic Engineering · doi:10.1016/j.ymben.2020.10.004 · Cited by 70
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
Bloomer, H., Khirallah, J., Li, Y., & Xu, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114087 · Cited by 75
Hairy CRISPR: Genome Editing in Plants Using Hairy Root Transformation
Kiryushkin, A. S., Ilina, E. L., Guseva, E. D., Pawlowski, K., & Demchenko, K. N. (2021) · Plants · doi:10.3390/plants11010051 · Cited by 70
Akram, F., Sahreen, S., Aamir, F., Haq, I. U., Malik, K. A., Imtiaz, M., Naseem, W., Nasir, N., & Waheed, H. M. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00501-4 · Cited by 72
Facioscapulohumeral muscular dystrophy: the road to targeted therapies
Tihaya, M. S., Mul, K., Balog, J., de Greef, J. C., Tapscott, S. J., Tawil, R., Statland, J. M., & van der Maarel, S. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00762-2 · Cited by 70
Cavazza, A., Molina-Estévez, F. J., Reyes, Á. P., Ronco-Díaz, V., Naseem, A., Malenšek, Š., Pečan, P., Santini, A., Heredia, P., Aguilar-González, A., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102457 · Cited by 78
An Adaptable Platform for Directed Evolution in Human Cells
Berman, C. M., Papa, L. J., Hendel, S. J., Moore, C., Suen, P., Weickhardt, A. F., Doan, N., Kumar, C. M., Uil, T. G., Butty, V. L., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10937 · Cited by 71
A CRISPR Interference Platform for Efficient Genetic Repression in Candida albicans
Wensing, L. F., Sharma, J., Uthayakumar, D., Proteau, Y., Chavez, A., & Shapiro, R. S. (2019) · mSphere · doi:10.1128/msphere.00002-19 · Cited by 71
Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
Brodehl, A., Ebbinghaus, H., Deutsch, M.-A., Gummert, J. F., Gärtner, A., Ratnavadivel, S., & Milting, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184381 · Cited by 73
CRISPR/Cas9 gene-editing strategies in cardiovascular cells
Vermersch, E., Jouve, C., & Hulot, J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz250 · Cited by 74
CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in Bacillus subtilis
Yu, S., Price, M. A., Wang, Y., Liu, Y., Guo, Y., Ni, X., Rosser, S. J., Bi, C., & Wang, M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00151 · Cited by 69
Programmable C‐to‐U RNA editing using the human APOBEC3A deaminase
Huang, X., Lv, J., Li, Y., Mao, S., Li, Z., Jing, Z., Sun, Y., Zhang, X., Shen, S., Wang, X., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020104741 · Cited by 71
Lim, Y., Arora, S., Schuster, S. L., Corey, L., Fitzgibbon, M., Wladyka, C. L., Wu, X., Coleman, I. M., Delrow, J. J., Corey, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24445-6 · Cited by 70
Systems-based rice improvement approaches for sustainable food and nutritional security
Verma, V. C., Vishal, B., Kohli, A., & Kumar, P. P. (2021) · Plant Cell Reports · doi:10.1007/s00299-021-02790-6 · Cited by 75
CRISPR-based engineering of phages for in situ bacterial base editing
Nethery, M. A., Hidalgo-Cantabrana, C., Roberts, A., & Barrangou, R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206744119 · Cited by 71
Breakthrough in CRISPR/Cas system: Current and future directions and challenges
Ali, A. R., Zafar, M. M., Farooq, Z., Ahmed, S. R., Ijaz, A., Anwar, Z., Abbas, H., Tariq, M. S., Tariq, H., Mustafa, M., et al. (2023) · Biotechnology Journal · doi:10.1002/biot.202200642 · Cited by 69
Wang, J., Xie, W., Li, N., Li, W., Zhang, Z., Fan, N., Ouyang, Z., Zhao, Y., Lai, C., Li, H., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.08.003 · Cited by 69
CRISPR/Cas9 Technology for Enhancing Desirable Traits of Fish Species in Aquaculture
Zhu, M., Sumana, S. L., Muhammad, A. M., Falayi, O. C., Shui, Y., Zhang, C., Zhu, J. X., & Su, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179299 · Cited by 64
Atoki, A. V., Aja, P. M., Shinkafi, T. S., Ondari, E. N., Adeniyi, I. A., Fasogbon, I. V., Dangana, R. S., Shehu, U. U., & Akin-Adewumi, A. (2024) · Fly · doi:10.1080/19336934.2024.2420453 · Cited by 78
Lung Cancer Heterogeneity and New Strategies for Drug Therapy
Wang, D. C., Wang, W. Y., Zhu, B., & Wang, X. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104523 · Cited by 69
Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID
Sasaguri, H., Nagata, K., Sekiguchi, M., Fujioka, R., Matsuba, Y., Hashimoto, S., Sato, K., Kurup, D., Yokota, T., & Saido, T. C. (2018) · Nature Communications · doi:10.1038/s41467-018-05262-w · Cited by 72
Harnessing CRISPR-Cas systems for precision engineering of designer probiotic lactobacilli
Goh, Y. J., & Barrangou, R. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.11.009 · Cited by 72
Zhang, W., MITCHELL, L. A., Bader, J. S., & Boeke, J. D. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-110704 · Cited by 71
Zhang, E., Neugebauer, M. E., Krasnow, N. A., & Liu, D. R. (2024) · Nature Communications · doi:10.1038/s41467-024-45969-7 · Cited by 68
Self-citationTools and targets: the dual role of plant viruses in CRISPR–Cas genome editing
Uranga, M., & Daròs, J. (2023) · The Plant Genome · doi:10.1002/tpg2.20220 · Cited by 68
Genetic engineering in organoids
Teriyapirom, I., Batista-Rocha, A. S., & Koo, B.-K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02029-z · Cited by 68
Genome editing technology and application in soybean improvement
Bao, A., Zhang, C., Huang, Y., Chen, H., Zhou, X., & Cao, D. (2020) · Oil Crop Science · doi:10.1016/j.ocsci.2020.03.001 · Cited by 68
In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing
Sinnamon, J. R., Kim, S. Y., Fisk, J. R., Song, Z., Nakai, H., Jeng, S., McWeeney, S. K., & Mandel, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107878 · Cited by 68
Applying gene editing to tailor precise genetic modifications in plants
Eck, J. M. V. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.010850 · Cited by 69
Tran, M. T. N., Khalid, M. K. N. M., Wang, Q., Walker, J. K. R., Lidgerwood, G. E., Dilworth, K. L., Lisowski, L., Pébay, A., & Hewitt, A. W. (2020) · Nature Communications · doi:10.1038/s41467-020-18715-y · Cited by 70
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
Rao, S., Yao, Y., & Bauer, D. E. (2021) · Genome Medicine · doi:10.1186/s13073-021-00857-3 · Cited by 72
Directed evolution in mammalian cells
Hendel, S. J., & Shoulders, M. D. (2021) · Nature Methods · doi:10.1038/s41592-021-01090-x · Cited by 68
Ravi, N. S., Wienert, B., Wyman, S. K., Bell, H. W., George, A., Mahalingam, G., Vu, J. T., Prasad, K. M., Bandlamudi, B. P., Devaraju, N., et al. (2022) · eLife · doi:10.7554/elife.65421 · Cited by 70
From pharmacogenetics to pharmaco-omics: Milestones and future directions
Auwerx, C., Sadler, M. C., Reymond, A., & Kutalik, Z. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100100 · Cited by 72
Metadata
- Authors
- Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- Venue
- Nature
- Published
- 2016-04-20
- Volume
- 533
- Issue
- 7603
- Pages
- 420-424
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4873371
- OpenAlex
- W2336828812
- Cited by
- 5,437
- References
- 36
- Citations by year
- 2026: 564 · 2025: 660 · 2024: 664 · 2023: 719 · 2022: 681 · 2021: 614 · 2020: 540 · 2019: 408 · 2018: 338 · 2017: 182 · 2016: 61
- FWCI
- 171.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences (T32GM008313, F32 GM 106601-2, F32GM106601, F32 GM 112366-2, R01GM065400, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- base editing, CRISPR/Cas9, cytidine deaminase, point mutation correction, Cas9 nickase, DNA repair, guide RNA, genome editing, human disease models
- MeSH terms
- APOBEC-1 Deaminase, RNA, Guide, CRISPR-Cas Systems, Animals, Base Sequence, Cell Line, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, DNA Repair, Genetic Engineering, Humans, Templates, Genetic, Uridine, Genes, p53, Genome, Point Mutation, Mice, Uracil-DNA Glycosidase, Apolipoprotein E4, DNA Cleavage, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
